Discover how BioDuro’s advanced LC-HRMS platform is transforming the way peptide-based drugs are evaluated for metabolic stability and biotransformation. This flyer outlines a powerful, unbiased approach to peptide metabolite profiling that uncovers both expected and unexpected metabolic pathways—enabling smarter lead optimization and more confident candidate selection.

• Comprehensive Metabolic Coverage: Simultaneously captures proteolytic and non-proteolytic biotransformations in a single workflow
• Unbiased Metabolite Discovery: Detects low-abundance and unexpected metabolites often missed by conventional methods
  • Actionable Insights for Design: Translates metabolite data into soft-spot identification and structure-metabolism relationships
• Fit-for-Purpose Assay Panels: Integrates gastrointestinal, hepatic, plasma, and cellular models to reflect real-world peptide metabolism

Download the flyer to explore how integrated peptide metabolite profiling can sharpen your DMPK strategy and de-risk your development path!